Tumbling Medtech Investment Records Leave A Hill To Climb In 2022

‘Superlative’ Best Describes Medtech And Healthtech Deal Activity And Performance In 2021

Listing all-time high medtech IPO and M&A activity, Silicon Valley Bank’s 2021 health care investments and exits report made good reading after the market uncertainties induced by the pandemic a year earlier. But where does the sector go now after such a sterling year?

alamy

Investment in health care companies in the US and Europe in 2021 reached $86.3bn, according to the latest annual investments and exits update from Silicon Valley Bank (SVB). This was a heady 64% up on the 2020 performance, with healthtech – up 157% ̶ leading the way.

Elsewhere, record numbers of medical device IPOs (24) and private M&A deals (those with at least $50m upfront) were reported in 2021

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Market Intelligence

More from In Vivo